PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
76.97%
Revenue growth above 1.5x 6203.T's 22.20%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
295.25%
Gross profit growth above 1.5x 6203.T's 60.32%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
115.96%
EBIT growth 50-75% of 6203.T's 192.38%. Martin Whitman would suspect suboptimal resource allocation.
117.36%
Operating income growth under 50% of 6203.T's 34400.00%. Michael Burry would be concerned about deeper cost or sales issues.
87.26%
Net income growth under 50% of 6203.T's 374.55%. Michael Burry would suspect the firm is falling well behind a key competitor.
87.27%
EPS growth under 50% of 6203.T's 373.41%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
87.27%
Diluted EPS growth under 50% of 6203.T's 373.41%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-88.96%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-88.96%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-88.96%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.53%
Net income/share CAGR at 50-75% of 6203.T's 193.58%. Martin Whitman might question if the firm’s product or cost base lags behind.
98.53%
5Y net income/share CAGR at 50-75% of 6203.T's 193.58%. Martin Whitman might see a shortfall in operational efficiency or brand power.
98.53%
3Y net income/share CAGR 50-75% of 6203.T's 193.58%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.83%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.84%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-3.86%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-23.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.